...
首页> 外文期刊>癌と化学療法 >A case of advanced gastric cancer effectively treated by combined chemotherapy of paclitaxel (TXL) and CDDP
【24h】

A case of advanced gastric cancer effectively treated by combined chemotherapy of paclitaxel (TXL) and CDDP

机译:通过紫杉醇(TXL)和CDDP的组合化疗有效治疗晚期胃癌的情况

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The patient was a 73-year-old man with unresectable advanced gastric cancer and celiac and supraclavicular lymph node metastases. Neoadjuvant chemotherapy consisting of paclitaxel (TXL) and CDDP was administered. TXL (80 mg/m2) and CDDP (25 mg/m2) was administered weekly on day 1, 8 and 15 as 1 cycle. After 4 cycles of TXL/CDDP administration, the lymph node metastases and gastric tumor had decreased almost completely in size and distal partial gastrectomy was performed. After surgery, the patient was treated with 4 courses of TXL/CDDP and has survived without recurrence to the present. TXL/CDDP is associated with few adverse events in hospital visits, and is thought to be an effective chemotherapy against advanced gastric cancer.
机译:该患者是一个73岁的男子,具有不可切除的晚期胃癌和腹腔和上皮淋巴结转移。 施用由紫杉醇(TXL)和CDDP组成的新辅助化学疗法。 每周1,8和15天,每周给予TX1(80mg / m2)和CDDP(25mg / m2)作为1个循环。 在4次TXL / CDDP给药后,淋巴结转移和胃肿瘤几乎完全降低,并且进行远端胃切除术。 手术后,患者用4种TXL / CDDP治疗,并在没有复发的情况下存活。 TXL / CDDP与医院访问中的一些不良事件有关,并被认为是针对晚期胃癌的有效化疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号